The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Official Title: Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
Study ID: NCT01960634
Brief Summary: This is a multi-centric translational study with biological samples collection. The aim of this study is to validate a method to detect BRAFV600 in blood samples. Samples: Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice. The treatment is not the aim of the study. Patients can be treated either with specific or no-specific drug.
Detailed Description:
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Hospital Infanta Cristina, Madrid, Badajoz, Spain
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, Spain
Hospital Costa del SOl, Marbella, Málaga, Spain
Hospital del Mar, Barcelona, , Spain
Hospital Universitario Quirón Dexeus, Barcelona, , Spain
Hospital Vall d'Hebron, Barcelona, , Spain
Hospital de la Santa Creu i Sant Pau, Barcelona, , Spain
Hospital Ramón y Cajal, Madrid, , Spain
Hospital Marques de Valdecilla, Santander, , Spain
Hospital Virgen de la Salud, Toledo, , Spain
Fundación Instituto Valenciano de Oncología, Valencia, , Spain
Hospital Miguel Servet, Zaragoza, , Spain
Name: María González Cao, MD
Affiliation: Hospital Universitario Quirón Dexeus
Role: STUDY_DIRECTOR